About DaVita Inc. Common Stock
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
2BB score and signals
DaVita Inc. Common Stock’s current 2BB score is 40 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 26 | Low |
| Momentum | 40 | Stable |
| Financial strength | 63 | Strong |
| Quality | 100 | Very Strong |
| Risk | 42 | Moderate |
Company facts
| CEO | Javier J. Rodriguez |
| Headquarters | Denver, Colorado, United States |
| Founded | 1992 |
| Employees | 78K |
| P/E ratio | 14.65 |
| 52-week range | $101.00 – $247.49 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-01 | — | 4.4575 | — | $3.65B |
| 2026-10-27 | — | 3.6141 | — | $3.54B |
| 2026-08-04 | — | 3.9212 | — | $3.53B |
| 2026-05-05 | 2.87 | 2.3412 | $3.42B | $3.39B |
Related companies
